A Singapore-based investor is actively seeking to acquire a controlling stake (≥50%) in a Vietnamese herbal manufacturing company with real production capability, regulatory compliance, and long-term growth potential.

This is a buy-to-build transaction, not a financial flip.

Transaction Overview

• Industry: Herbal / Botanical Manufacturing
• Deal type: M&A – majority acquisition
• Target ownership: ≥50%
• Transaction size: USD 10–50 million
• Target market: Vietnam
• Investor origin: Singapore
• Timing reference: March 2026

The investor is open to full acquisition or majority partnership, depending on the structure and quality of the target company.

What the Investor Is Strictly Screening For

This opportunity is highly selective. The investor is focused on operational substance, not just licenses or land.

1. Legal & Compliance Readiness

The target company must already meet regulatory standards, not promise them later:

• Valid operating licenses
• Factory certified under GMP / GACP or equivalent
• Full traceability documentation for raw materials

This is non-negotiable.

2. Manufacturing Capability

The investor wants a factory that already works:

• Stable production capacity
• Proven QC/QA systems in place
• Factory scale of at least 1 hectare

They are not interested in pilot plants or semi-manual workshops.

3. Raw Material Control

This is a critical value driver:

• Standardized, clean herbal inputs
• Raw materials tested and certified
• A stable, sustainable supply chain, not spot buying

Vertical control or strong supplier relationships are a major advantage.

4. R&D and Formulation Capability

Beyond toll manufacturing:

• In-house or embedded R&D team
• Ability to develop, improve, or customize formulations
• Capability to support product testing and validation

This signals long-term competitiveness, not commodity production.

5. Track Record and Reputation

• Minimum 3 years of operating history
• Consistent quality output
• A reputation that can withstand international due diligence

Why This Matters for Vietnamese Herbal Manufacturers

Many herbal manufacturers in Vietnam are strong operationally but face structural ceilings:

• Limited capital for scaling or automation
• Difficulty upgrading compliance to international markets
• Weak global distribution and branding power

This investor is not just buying assets. They are buying a platform to scale:

• Capacity expansion
• Process standardization
• Export readiness
• Regional or global market access

For the right company, this is a chance to move from local manufacturing to international positioning.

Who This Opportunity Is For

You should pay attention if your company:

• Already operates a compliant herbal manufacturing facility
• Controls or secures raw material sourcing
• Understands GMP, QC/QA, and documentation discipline
• Is open to strategic ownership change to unlock growth

This is not suitable if:

• Your factory exists mainly on paper
• Compliance is partial or pending
• The business relies purely on trading or outsourcing

A Strategic Note to Manufacturing Leaders

This M&A opportunity is not an isolated case. It is part of a broader pipeline of verified acquisition and investment mandates targeting Vietnamese manufacturing companies.

Companies that stay connected to our manufacturing platform gain:

• Early visibility into real buyer demand
• A clearer understanding of how foreign investors evaluate factories
• The ability to position themselves before capital is urgently needed

Serious manufacturing companies do not wait for opportunity.
They make sure opportunity can find them.

Further Discussion

If your company meets the above criteria or you would like to explore this M&A opportunity in more detail,
you may submit your information via the contact form below.

All discussions are handled on a confidential, selective, and practical basis, focusing on businesses with real operational capability and long-term scalability.